{
  "id": "d2b3621a5623635a",
  "title": "STAT+: Pharmalittle: We\u2019re reading about Lilly bulking up on weight-loss drugs, scrutiny of a 340B contractor, and more",
  "description": "And other pharma news from the Pharmalot campus today",
  "content": "And other pharma news from the Pharmalot campus today",
  "source": "STAT",
  "source_url": "https://www.statnews.com/pharmalot/2026/02/13/lilly-glp1-obesity-340b-nih-hiv-aids/?utm_campaign=rss",
  "published_at": "2026-02-13T14:36:17+00:00",
  "fetched_at": "2026-02-14T00:29:18.398832+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Pharmalittle: We\u2019re reading about Lilly bulking up on weight-loss drugs, scrutiny of a 340B contractor, and more",
    "description": "And other pharma news from the Pharmalot campus today",
    "url": "https://www.statnews.com/pharmalot/2026/02/13/lilly-glp1-obesity-340b-nih-hiv-aids/?utm_campaign=rss",
    "published": "2026-02-13T14:36:17+00:00",
    "source": "STAT"
  }
}